Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study

References

• AlHilli MM, Mariani A, Bakkum-Gamez JN, et al. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer. Gynecol Oncol. 2014;133(3):485–493. doi:10.1016/j.ygyno.2014.03.567.
   PubMed Web of Science ®Google Scholar
• Benedetti PP, Basile S, Salerno MG et al. Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma. Am J Obstet Gynecol. 2014;210(4):363.e1–363.e10. doi:10.1016/j.ajog.2013.12.025.
   Web of Science ®Google Scholar
• Kitchener H, Swart A, Qian Q, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet (London, England). 2009;373:125–136.
   PubMed Web of Science ®Google Scholar
• Dowdy SC, Borah BJ, Bakkum-Gamez JN, et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol. 2012;127(1):5–10. doi:10.1016/j.ygyno.2012.06.035.
   PubMed Web of Science ®Google Scholar
• Garbe C, Eigentler TK. Diagnosis and treatment of cutaneous melanoma: state of the art 2006. Melanoma Res. 2007;17(2):117–127. doi:10.1097/CMR.0b013e328042bb36.
   PubMed Web of Science ®Google Scholar
• Oonk MH, Hollema H, de Hullu JA, et al. Prediction of lymph node metastases in vulvar cancer: a review. Int J Gynecol Cancer. 2006;16(3):963–971. doi:10.1111/j.1525-1438.2006.00387.x.
   PubMed Web of Science ®Google Scholar
• Sato K, Shigenaga R, Ueda S, et al. Sentinel lymph node biopsy for breast cancer. J Surg Oncol. 2007;96(4):322–329. doi:10.1002/jso.20866.
   PubMed Web of Science ®Google Scholar
• Kang S, Yoo HJ, Hwang JH, Lim M-C, et al. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol. 2011;123(3):522–527. doi:10.1016/j.ygyno.2011.08.034.
   PubMed Web of Science ®Google Scholar
• Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med. 2007;48:78S–88S.
   PubMed Web of Science ®Google Scholar
• Bese T, Sal V, Demirkiran F, et al. The combination of preoperative fluorodeoxyglucose positron emission tomography/computed tomography and sentinel lymph node mapping in the surgical management of endometrioid endometrial cancer. Int J Gynecol Cancer. 2016;26(7):1228–1238. doi:10.1097/IGC.0000000000000773.
   PubMed Web of Science ®Google Scholar
• Bollineni VR, Ytre-Hauge S, Bollineni-Balabay O, et al. High diagnostic value of 18F-FDG PET/CT in endometrial cancer: systematic review and meta-analysis of the literature. J Nucl Med. 2016;57(6):879–885. doi:10.2967/jnumed.115.170597.
   PubMed Web of Science ®Google Scholar
• Signorelli M, Crivellaro C, Buda A, et al. Staging of high-risk endometrial cancer with PET/CT and sentinel lymph node mapping. Clin Nucl Med. 2015;40(10):780–785. doi:10.1097/RLU.0000000000000852.
   PubMed Web of Science ®Google Scholar
• Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer. 2016;26(1):2–30. doi:10.1097/IGC.0000000000000609.
   PubMed Web of Science ®Google Scholar
• Jewell EL, Huang JJ, Abu-Rustum NR, et al. Detection of sentinel lymph nodes in minimally invasive surgery u ± g indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies. Gynecol Oncol. 2014;133(2):274–277. doi:10.1016/j.ygyno.2014.02.028.
   PubMed Web of Science ®Google Scholar
• Rossi EC, Ivanova A, Boggess JF. Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study. Gynecol Oncol. 2012;124(1):78–82. doi:10.1016/j.ygyno.2011.09.025.
   PubMed Web of Science ®Google Scholar
• Holloway RW, Bravo RAM, Rakowski JA, et al. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging. Gynecol Oncol. 2012;126(1):25–29. doi:10.1016/j.ygyno.2012.04.009.
   PubMed Web of Science ®Google Scholar
• Delpech Y, Coutant C, Darai E, et al. Sentinel lymph node evaluation in endometrial cancer and the importance of micrometastases. Surg Oncol. 2008;17(3):237–245. doi:10.1016/j.suronc.2008.04.001.
   PubMed Web of Science ®Google Scholar
• Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016;27(1):16–41. doi:10.1093/annonc/mdv484.
   PubMed Web of Science ®Google Scholar
• Ballester M, Naoura I, Chéreau E, et al. Sentinel node biopsy upstages patients with presumed low-and intermediate-risk endometrial cancer: results of a multicenter study. Ann Surg Oncol.. 2013;20(2):407–412. doi:10.1245/s10434-012-2683-x.
   PubMed Web of Science ®Google Scholar
• How J, Lau S, Press J, et al. Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: a prospective study. Gynecol Oncol. 2012;127(2):332–337. doi:10.1016/j.ygyno.2012.08.018.
   PubMed Web of Science ®Google Scholar
• Solima E, Martinelli F, Ditto A, et al. Diagnostic accuracy of sentinel node in endometrial cancer by using hysteroscopic injection of radiolabeled tracer. Gynecol Oncol. 2012;126(3):419–423. doi:10.1016/j.ygyno.2012.05.025.
   PubMed Web of Science ®Google Scholar
• Yabushita H, Shimazu M, Yamada H, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol. 2001;80(2):139–144. doi:10.1006/gyno.2000.6067.
   PubMed Web of Science ®Google Scholar
• Touhami O, Grégoire J, Renaud M-C, et al. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer. Gynecol Oncol. 2017;147(3):549. doi:10.1016/j.ygyno.2017.09.014.
   PubMed Web of Science ®Google Scholar
• Abu‐Rustum NR. Update on sentinel node mapping in uterine cancer: 10‐year experience at Memorial Sloan–Kettering Cancer Center. J Obstet Gynaecol Res. 2014;40:327–334.
   PubMed Web of Science ®Google Scholar
• Abu-Rustum NR. Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. J Natl Compr Canc Netw. 2014;12(2):288–297. doi:10.6004/jnccn.2014.0026.
   PubMed Web of Science ®Google Scholar
• How JO, Amajoud Z, Lau S, et al. Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Minerva Ginecol. 2018;70:194–214.
   Web of Science ®Google Scholar
• Holloway RW, Abu-Rustum NR, Backes FJ, et al. Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol. 2017;146(2):405–415. doi:10.1016/j.ygyno.2017.05.027.
   PubMed Web of Science ®Google Scholar
• Ruiz R, Gorostidi M, Jaunarena I, et al. Sentinel node biopsy in endometrial cancer with dual cervical and fundal indocyanine green injection. Int J Gynecol Cancer. 2018;28(1):139–144. doi:10.1097/IGC.0000000000001151.
   PubMed Web of Science ®Google Scholar
• Perrone AM, Casadio P, Formelli G, et al. Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol Oncol. 2008;111(1):62–67. doi:10.1016/j.ygyno.2008.05.032.
   PubMed Web of Science ®Google Scholar
• Martinelli F, Ditto A, Signorelli M, et al. Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: a single center evaluation over 200 cases. Gynecol Oncol. 2017;146(3):525–530.
   PubMed Web of Science ®Google Scholar
• Wang L, Liu F. Meta-analysis of laparoscopy sentinel lymph node mapping in endometrial cancer. Arch Gynecol Obstet. 2018;298(3):505–510. doi:10.1007/s00404-018-4845-y.
   PubMed Web of Science ®Google Scholar
• Tanner E, Puechl A, Levinson K, et al. Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer. Gynecol Oncol. 2017;147(3):535–540. doi:10.1016/j.ygyno.2017.10.020.
   PubMed Web of Science ®Google Scholar
• Ducie JA, Eriksson AGZ, Ali N, et al. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease. Gynecol Oncol. 2017;147(3):541–548. doi:10.1016/j.ygyno.2017.09.030.
   PubMed Web of Science ®Google Scholar
• Buda A, Di Martino G, Restaino S, et al. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: an Italian retrospective analysis of two reference centers. Gynecol Oncol. 2017;147(3):528. doi:10.1016/j.ygyno.2017.09.033.
   PubMed Web of Science ®Google Scholar
• Smith AJB, Fader AN, Tanner EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216:459–476. e10. doi:10.1016/j.ajog.2016.11.1033.
   PubMed Web of Science ®Google Scholar
• Soliman PT, Westin SN, Dioun S, et al. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol. 2017;146(2):234–239. doi:10.1016/j.ygyno.2017.05.016.
   PubMed Web of Science ®Google Scholar
• Stelloo E, Nout RA, Osse EM, et al. Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts. Clin Cancer Res. 2016;22(16):4215–4224. doi:10.1158/1078-0432.CCR-15-2878.
   PubMed Web of Science ®Google Scholar
• Di Donato V, Iacobelli V, Schiavi MC, et al. P, Impact of hormone receptor status and Ki-67 expression on disease-free survival in patients affected by high-risk endometrial cancer. Int J Gynecol Cancer. 2018;28(3):505–513. doi:10.1097/IGC.0000000000001191.
   PubMed Web of Science ®Google Scholar
• Talhouk A, McConechy MK, Leung S, et al. Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer. Cancer. 2017;123(5):802–813. doi:10.1002/cncr.30496.
   PubMed Web of Science ®Google Scholar